Therapeutic Effects of Neurofeedback in Anorexia Nervosa
NCT ID: NCT01390493
Last Updated: 2015-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
12 participants
INTERVENTIONAL
2010-10-31
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To examine whether AN patients are able to control their alpha-activity through neurofeedback.
2. To examine the effects of neurofeedback on symptomatology and personality variables in AN patients.
3. To examine the long-term effects of neurofeedback in the treatment of AN.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neural Correlates of Reward and Symptom Expression in Anorexia Nervosa
NCT03275545
Facilitators and Barriers in Anorexia Nervosa - Treatment Initiation
NCT03713541
Stress and Neurofeedback in Anorexia Nervosa
NCT05834816
Effectiveness of Family-Based Versus Individual Psychotherapy in Treating Adolescents With Anorexia Nervosa
NCT00149786
Comparison of Two Types of Family Therapy in the Treatment of Adolescent Anorexia Nervosa
NCT00610753
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There is evidence that alpha-neurofeedback leads to an increase in positive therapy outcome in clinical populations by changing long-lasting EEG frequency patterns. The use of an EEG-guided relaxation paradigm has been shown to be associated with well-being and improvements in pathology of psychiatric patients.
In the present study the effects of alpha-training on EEG activity, mood, personality, well-being, blood parameters, and heart frequency will be evaluated in a sample of anorectic girls (12-18 years).
The subjects are trained with at least 10 sessions alpha-neurofeedback, in order to enhance individual alpha frequency, with spectral resting EEG, EKG, blood samples, ERP-measures and psychometric measures assessed before and after training. Neurofeedback is conducted over a period of five weeks, with each participant receiving two training sessions per-week. Neurofeedback is administered using USBAmp-EEG system.
For better surveillance of training effects there are two non-treatment control groups. A patient group receiving conventional therapy programme of the Psychosomatic Division of the Pediatric Department at the University Hospital Graz and a healthy control group.
A twelve-week follow-up study is carried out in order to document long-term effects of alpha-neurofeedback training in AN patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
neurofeedback, alpha power
neurofeedback training
training of individual alpha frequency, 10 sessions, each 15 min
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
neurofeedback training
training of individual alpha frequency, 10 sessions, each 15 min
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
12 Years
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Graz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nina Lackner, Mag.
Role: PRINCIPAL_INVESTIGATOR
Department of Psychology, Karl-Franzens-University Graz
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NEUROAN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.